← FDA Drug Approvals (Drugs@FDA)

LORATADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 2003-11-07

Drug application

FDA Application #

ANDA075505

Application type

Abbreviated New Drug Application (Generic)

Brand name

LORATADINE

Generic name

Loratadine

Active ingredients

LORATADINE

Dosage form

SYRUP

Route

ORAL

Marketing status

Discontinued

Sponsor

TEVA

First approval

2003-11-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown